Alfama's Acquisition

Alfama was acquired by Proterris on May 04, 2017.

Alfama specializes in the development of Carbon Monoxide-Releasing Molecules (CORMs) for therapy. The company produces CORMs and obtained exceptional results in various animal models of chronic and ac…

Articles about Alfama's Acquisition: